Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01701986
Title Gemcitabine/Clofarabine/Busulfan and Allogeneic Transplantation for Aggressive Lymphomas
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

Tacrolimus

Rituximab

Filgrastim

Mycophenolate mofetil

anti-thymocyte globulin

Busulfan + Clofarabine + Gemcitabine

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.